Ulf Dietrich Kahlert (U D Kahlert, Christoph Janiak, Ulf Kahlert, Ulf D Kahlert)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 43

Top Venues

F1000Research

Pharmaceutics

Cancers

Pharmacological reports : PR

Heinrich Heine University Düsseldorf

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Heinrich Heine University Düsseldorf Oct 01 2017

Germany

Department head :: Preclinics

Heinrich Heine University Düsseldorf Jan 01 2016 - Sep 30 2017

Germany

Group leader :: Neurosurgery

Publications

Maximilian Dölling, Mirhasan Rahimli, Jonas Pachmann, Malik Szep, Sara Al-Madhi, Mihailo Andric, Ulf Dietrich Kahlert, Tobias Hofmann, Johannes Boettcher, Luis Enrique Munoz, Martin Herrmann, Aristotelis Perrakis, Roland Siegfried Croner
Hidden Appendicoliths and Their Impact on the Severity and Treatment of Acute Appendicitis. Journal of clinical medicine 13 (14) (2024)
Marilyn Kaul, Ahmed Y Sanin, Wenjie Shi, Christoph Janiak, Ulf Dietrich Kahlert
Nanoformulation of dasatinib cannot overcome therapy resistance of pancreatic cancer cells with low LYN kinase expression. Pharmacological reports : PR (2024)
Tal Levy, Kai Voeltzke, Laura Hruby, Khawla Alasad, Zuelal Bas, Marteinn T Snaebjornsson, Ran Marciano, Katerina Scharov, Mélanie Planque, Kim Vriens, Stefan Christen, Cornelius Maximilian Funk, Christina Hassiepen, Alisa Kahler, Beate Heider, Daniel Picard, Jonathan K M Lim, Anja Stefanski, Katja Bendrin, Andres Vargas-Toscano, Ulf Dietrich Kahlert, Kai Stühler, Marc Remke, Moshe Elkabets, Thomas G P Grünewald, Andreas S Reichert, Sarah-Maria Fendt, Almut Schulze, Guido Reifenberger, Barak Rotblat, Gabriel Leprivier
mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism. Nature communications 15 (1) (2024)
Marilyn Kaul, Ahmed Y Sanin, Wenjie Shi, Christoph Janiak, Ulf Dietrich Kahlert
Nanoformulation of dasatinib cannot overcome therapy resistance of pancreatic cancer cells with low LYN kinase expression. Pharmacological reports : PR 76 (4) (2024)
Maximilian Dölling, Mirhasan Rahimli, Jonas Pachmann, Malik Szep, Sara Al-Madhi, Mihailo Andric, Ulf Dietrich Kahlert, Tobias Hofmann, Johannes Boettcher, Luis Enrique Munoz, Martin Herrmann, Aristotelis Perrakis, Roland Siegfried Croner
Hidden Appendicoliths and Their Impact on the Severity and Treatment of Acute Appendicitis. Journal of clinical medicine 13 (14) (2024)
Marilyn Kaul, Ahmed Y Sanin, Wenjie Shi, Christoph Janiak, Ulf Dietrich Kahlert
Nanoformulation of dasatinib cannot overcome therapy resistance of pancreatic cancer cells with low LYN kinase expression. Pharmacological reports : PR 76 (4) (2024)
Tal Levy, Kai Voeltzke, Laura Hruby, Khawla Alasad, Zuelal Bas, Marteinn T Snaebjornsson, Ran Marciano, Katerina Scharov, Mélanie Planque, Kim Vriens, Stefan Christen, Cornelius Maximilian Funk, Christina Hassiepen, Alisa Kahler, Beate Heider, Daniel Picard, Jonathan K M Lim, Anja Stefanski, Katja Bendrin, Andres Vargas-Toscano, Ulf Dietrich Kahlert, Kai Stühler, Marc Remke, Moshe Elkabets, Thomas G P Grünewald, Andreas S Reichert, Sarah-Maria Fendt, Almut Schulze, Guido Reifenberger, Barak Rotblat, Gabriel Leprivier
mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism. Nature communications 15 (1) (2024)
Maximilian Dölling, Mirhasan Rahimli, Jonas Pachmann, Malik Szep, Sara Al-Madhi, Mihailo Andric, Ulf Dietrich Kahlert, Tobias Hofmann, Johannes Boettcher, Luis Enrique Munoz, Martin Herrmann, Aristotelis Perrakis, Roland Siegfried Croner
Hidden Appendicoliths and Their Impact on the Severity and Treatment of Acute Appendicitis. Journal of clinical medicine 13 (14) (2024)
Tal Levy, Kai Voeltzke, Laura Hruby, Khawla Alasad, Zuelal Bas, Marteinn T Snaebjornsson, Ran Marciano, Katerina Scharov, Mélanie Planque, Kim Vriens, Stefan Christen, Cornelius Maximilian Funk, Christina Hassiepen, Alisa Kahler, Beate Heider, Daniel Picard, Jonathan K M Lim, Anja Stefanski, Katja Bendrin, Andres Vargas-Toscano, Ulf Dietrich Kahlert, Kai Stühler, Marc Remke, Moshe Elkabets, Thomas G P Grünewald, Andreas S Reichert, Sarah-Maria Fendt, Almut Schulze, Guido Reifenberger, Barak Rotblat, Gabriel Leprivier
mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism. Nature communications 15 (1) (2024)
Marilyn Kaul, Ahmed Y Sanin, Wenjie Shi, Christoph Janiak, Ulf Dietrich Kahlert
Nanoformulation of dasatinib cannot overcome therapy resistance of pancreatic cancer cells with low LYN kinase expression. Pharmacological reports : PR 76 (4) (2024)
Wenjie Shi, Thomas Wartmann, Sara Accuffi, Sara Al-Madhi, Aristotelis Perrakis, Christoph Kahlert, Alexander Link, Marino Venerito, Verena Keitel-Anselmino, Christiane Bruns, Roland S Croner, Yue Zhao, Ulf Dietrich Kahlert
Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer. British journal of cancer (2023)
Lennard M Wurm, Björn Fischer, Volker Neuschmelting, David Reinecke, Igor Fischer, Roland S Croner, Roland Goldbrunner, Michael C Hacker, Jakub Dybaś, Ulf Dietrich Kahlert
Rapid, label-free classification of glioblastoma differentiation status combining confocal Raman spectroscopy and machine learning. The Analyst (2023)
Qiushi Yin, Qiuxi Yang, Wenjie Shi, Ulf Dietrich Kahlert, Zhongyi Li, Shibu Lin, Qifeng Song, Weiqiang Fan, Li Wang, Yi Zhu, Xiaolong Huang
Mendelian Randomization Analyses of Chronic Immune-Mediated Diseases, Circulating Inflammatory Biomarkers, and Cytokines in Relation to Liver Cancer. Cancers 15 (11) (2023)
N Z Mehjardi, J Kessler, A Y Sanin, D Picard, P Westhoff, Ann-Christin Nickel, C Uhlmann, W Shi, H J Steiger, Marc Remke, I Fischer, D Vordermark, R S Croner, Ulf Dietrich Kahlert
The development of a hiPSC-based platform to identify tissue-dependencies of IDH1 R132H. Cell death discovery 9 (1) (2023)
Nadezda Y Knauer, Mariya I Meschaninova, Sajjad Muhammad, Daniel Hänggi, Jean-Pierre Majoral, Ulf Dietrich Kahlert, Vladimir Kozlov, Evgeny K Apartsin
Effects of Dendrimer-microRNA Nanoformulations against Glioblastoma Stem Cells. Pharmaceutics 15 (3) (2023)
Nadezda Y Knauer, Mariya I Meschaninova, Sajjad Muhammad, Daniel Hänggi, Jean-Pierre Majoral, Ulf Dietrich Kahlert, Vladimir Kozlov, Evgeny K Apartsin
Effects of Dendrimer-microRNA Nanoformulations against Glioblastoma Stem Cells. Pharmaceutics 15 (3) (2023)
Nadezda Y Knauer, Mariya I Meschaninova, Sajjad Muhammad, Daniel Hänggi, Jean-Pierre Majoral, Ulf Dietrich Kahlert, Vladimir Kozlov, Evgeny K Apartsin
Effects of Dendrimer-microRNA Nanoformulations against Glioblastoma Stem Cells. Pharmaceutics 15 (3) (2023)
Kumudesh Mishra, Mária Péter, Anna Maria Nardiello, Guy Keller, Victoria Llado, Paula Fernández-García, Ulf Dietrich Kahlert, Dinorah Barasch, Ann Saada, Zsolt Török, Gábor Balogh, Pablo Vicente Escribá, Stefano Piotto, Or Kakhlon
Multifaceted Analyses of Isolated Mitochondria Establish the Anticancer Drug 2-Hydroxyoleic Acid as an Inhibitor of Substrate Oxidation and an Activator of Complex IV-Dependent State 3 Respiration. Cells 11 (3) (2022)
Evgeny K Apartsin, Nadezda Y Knauer, Ulf Dietrich Kahlert, Anne-Marie Caminade
Amphiphilic Triazine-Phosphorus Metallodendrons Possessing Anti-Cancer Stem Cell Activity. Pharmaceutics 14 (2) (2022)
Nadezhda Knauer, Valeria Arkhipova, Guanzhang Li, Michael Hewera, Ekaterina A Pashkina, Phuong-Hien Nguyen, Mariya I Meschaninova, Vladimir Kozlov, Wei Zhang, Roland Siegfried Croner, Anne-Marie Caminade, Jean-Pierre Majoral, Evgeny K Apartsin, Ulf Dietrich Kahlert
In Vitro Validation of the Therapeutic Potential of Dendrimer-Based Nanoformulations against Tumor Stem Cells. International journal of molecular sciences 23 (10) (2022)
Timo Sander, Joly Ghanawi, Emma Wilson, Sajjad Muhammad, Malcolm Robert MacLeod, Ulf Dietrich Kahlert
Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research. BMJ open science 6 (1) (2022)
Elham Poonaki, Ann-Christin Nickel, Mehdi Shafiee Ardestani, Lars Rademacher, Marilyn Kaul, Evgeny K Apartsin, Sven G Meuth, Ali Gorji, Ulf Dietrich Kahlert, Ulf Dietrich Kahlert
CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells. International journal of molecular sciences 23 (10) (2022)
Wenjie Shi, Chen Li, Thomas Wartmann, Christoph Kahlert, Renfei Du, Aristotelis Perrakis, Thomas Brunner, Roland Siegfried Croner, Ulf Dietrich Kahlert
Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents. Journal of personalized medicine 12 (3) (2022)
Guanzhang Li, Ting-Wei Chen, Ann-Christin Nickel, Sajjad Muhammad, Hans Jakob Steiger, Theophilos Tzaridis, Daniel Hänggi, Reinhard Zeidler, Wei Zhang, Ulf Dietrich Kahlert
Carbonic Anhydrase XII is a Clinically Significant, Molecular Tumor-Subtype Specific Therapeutic Target in Glioma with the Potential to Combat Invasion of Brain Tumor Cells. OncoTargets and therapy 14 (2021)
Maria Victoria Martinez-Dominguez, Alja Zottel, Neja Šamec, Ivana Jovčevska, Can Dincer, Ulf Dietrich Kahlert, Ann-Christin Nickel
Current Technologies for RNA-Directed Liquid Diagnostics. Cancers 13 (20) (2021)
Igor Fischer, Maria Victoria Martinez-Dominguez, Daniel Hänggi, Ulf Dietrich Kahlert
Reducing sources of variance in experimental procedures in in vitro research. F1000Research 10 (2021)
Hammad Ahmed, Mahtab Ahmad Khan, Ulf Dietrich Kahlert, Mika Niemelä, Daniel Hänggi, Shafqat Rasul Chaudhry, Sajjad Muhammad
Role of Adaptor Protein Myeloid Differentiation 88 (MyD88) in Post-Subarachnoid Hemorrhage Inflammation: A Systematic Review. International journal of molecular sciences 22 (8) (2021)
Dilaware Khan, Ann-Christin Nickel, Sebastian Jeising, Constanze Uhlmann, Sajjad Muhammad, Daniel Hänggi, Igor Fischer, Ulf Dietrich Kahlert
Testing the Stability of Drug Resistance on Cryopreserved, Gene-Engineered Human Induced Pluripotent Stem Cells. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Beatriz Giesen, Ann-Christin Nickel, Juri Barthel, Ulf Dietrich Kahlert, Ulf Dietrich Kahlert
Augmented Therapeutic Potential of Glutaminase Inhibitor CB839 in Glioblastoma Stem Cells Using Gold Nanoparticle Delivery. Pharmaceutics 13 (2) (2021)
Satoshi Nakata, Ming Yuan, Jeffrey A Rubens, Ulf Dietrich Kahlert, Jarek Maciaczyk, Eric H Raabe, Charles G Eberhart
BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets. International journal of molecular sciences 22 (8) (2021)
Katharina Koch, Rudolf Hartmann, Abigail Kora Suwala, Dayana Herrera Rios, Marcel Alexander Kamp, Michael Sabel, Hans-Jakob Steiger, Dieter Willbold, Ingo G H Schmidt-Wolf, Ulf Dietrich Kahlert, Jarek Maciaczyk
Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs). Cancers 13 (23) (2021)
Sajjad Muhammad, Shafqat Rasul Chaudhry, Ulf Dietrich Kahlert, Mika Niemelä, Daniel Hänggi
Brain Immune Interactions-Novel Emerging Options to Treat Acute Ischemic Brain Injury. Cells 10 (9) (2021)
Michael Hewera, Daniel Hänggi, Björn Gerlach, Ulf Dietrich Kahlert
eLabFTW as an Open Science tool to improve the quality and translation of preclinical research. F1000Research 10 (2021)
Sajjad Muhammad, Igor Fischer, Soheil Naderi, Morteza Faghih Jouibari, Sheikhrezaei Abdolreza, Alireza Jalali, Sara Aslzadeh, Mahsa Mashayekhi, Mohaddeseh Zojaji, Ulf Dietrich Kahlert, Daniel Hänggi
Systemic Inflammatory Index Is a Novel Predictor of Intubation Requirement and Mortality after SARS-CoV-2 Infection. Pathogens (Basel, Switzerland) 10 (1) (2021)
Michael Hewera, Daniel Hänggi, Björn Gerlach, Ulf Dietrich Kahlert
eLabFTW as an Open Science tool to improve the quality and translation of preclinical research. F1000Research 10 (2021)
Di Wang, Wenhua Fan, Fan Wu, Zhongfang Shi, Zhiliang Wang, Mingchen Yu, You Zhai, Yuanhao Chang, Changqing Pan, Guanzhang Li, Ulf Dietrich Kahlert, Wei Zhang
Clinical Characterization and Immunosuppressive Regulation of CD161 (KLRB1) in Glioma through 916 Samples. Cancer science (2021)
Andres Vargas-Toscano, Ulf Dietrich Kahlert, Michael Sabel, Ulf Dietrich Kahlert
A Preclinical Pipeline for Translational Precision Medicine-Experiences from a Transdisciplinary Brain Tumor Stem Cell Project. Journal of personalized medicine 11 (9) (2021)
Michael Hewera, Daniel Hänggi, Björn Gerlach, Ulf Dietrich Kahlert
eLabFTW as an Open Science tool to improve the quality and translation of preclinical research. F1000Research 10 (2021)
Igor Fischer, Maria Victoria Martinez-Dominguez, Daniel Hänggi, Ulf Dietrich Kahlert
Reducing sources of variance in experimental procedures in in vitro research. F1000Research 10 (2021)
Michael Hewera, Ann-Christin Nickel, Nina Knipprath, Sajjad Muhammad, Xiaolong Fan, Hans-Jakob Steiger, Daniel Hänggi, Ulf Dietrich Kahlert
An inexpensive and easy-to-implement approach to a Quality Management System for an academic research lab. F1000Research (2020)
Andres Vargas-Toscano, Dilaware Khan, Ann-Christin Nickel, Michael Hewera, Marcel Alexander Kamp, Igor Fischer, Hans-Jakob Steiger, Wei Zhang, Sajjad Muhammad, Daniel Hänggi, Ulf Dietrich Kahlert
Robot technology identifies a Parkinsonian therapeutics repurpose to target stem cells of glioblastoma. CNS oncology 9 (2) (2020)
Andres Vargas-Toscano, Ann-Christin Nickel, Guanzhang Li, Marcel Alexander Kamp, Sajjad Muhammad, Gabriel Leprivier, Ellen Fritsche, Roger A Barker, Michael Sabel, Hans-Jakob Steiger, Wei Zhang, Daniel Hänggi, Ulf Dietrich Kahlert
Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide. Cancers 12 (12) (2020)
Igor Fischer, Ann-Christin Nickel, Nan Qin, Kübra Taban, David Pauck, Hans-Jakob Steiger, Marcel Kamp, Sajjad Muhammad, Daniel Hänggi, Ellen Fritsche, Marc Remke, Ulf Dietrich Kahlert
Different Calculation Strategies Are Congruent in Determining Chemotherapy Resistance of Brain Tumors In Vitro. Cells 9 (12) (2020)

Ulf Dietrich Kahlert.css-eqlu8i{font-size:small;padding-left:4px;} (U D Kahlert, Christoph Janiak, Ulf Kahlert, Ulf D Kahlert)

Publication Activity (10 Years)

Top Topics

Top Venues

Ulf Dietrich Kahlert (U D Kahlert, Christoph Janiak, Ulf Kahlert, Ulf D Kahlert)